NCT00533923: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders |
|
|
| Completed | 2 | 25 | US | Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF, Cytoxan;, Fludara;, Leukine; | Beth Israel Deaconess Medical Center, Bayer | AML, ALL, CLL, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma, Aplastic Anemia, Myeloproliferative Disorder | 01/07 | 01/07 | | |
NCT00784719: A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye. |
|
|
| Completed | 1/2 | 327 | US | CP-690,550, Cyclosporine, CP-690,550 Vehicle | Pfizer | Dry Eye Syndromes | 10/09 | 10/09 | | |
